Low-level resistance to ciprofloxacin in non-Typhi Salmonella enterica isolated from human gastroenteritis in Dakar, Senegal (2004-2006)

International Journal of Antimicrobial Agents

Volumn 31, Issue 6, 2008, Pages 581-582

  Sire, Jean Marie ^a   Garin, Benoit ^a   Macondo, Edgard Adam ^b  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

^b Laboratoire Bio24   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ENROFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; DRUG EFFICACY; GASTROENTERITIS; HUMAN; LETTER; NONHUMAN; POULTRY; PREVALENCE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SENEGAL; SEROTYPING;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; GASTROENTERITIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SENEGAL;

EID: 43549123504     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.01.014     Document Type: Letter

References (7)

1. Stevenson J.E., Gay K., Barrett T.J., Medalla F., Chiller T.M., and Angulo F.J. Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003. Antimicrob Agents Chemother 51 (2007) 195-197
2. Comité de l'Antibiogramme de la Société Française de Microbiologie: Communiqué 2007 (Edition de janvier 2007). http://www.sfm.asso.fr. [accessed 23 November 2007].
3. Hakanen A., Kotilainen P., Jalava J., Siitonen A., and Huovinen P. Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 37 (1999) 3572-3577
4. Streit J.M., Jones R.N., Toleman M.A., Stratchounski L.S., and Fritsche T.R. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int J Antimicrob Agents 27 (2006) 367-375
5. Hakanen A., Kotilainen P., Pitkänen S., Huikko S., Siitonen A., and Huovinen P. Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients. J Clin Microbiol 57 (2006) 569-572
6. Molback K., Gerner-Smidt P., and Wegener H.C. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg Infect Dis 8 (2002) 514-515
7. Cardinale E., Perrier-Gros-Claude J.D., Rivoal K., Rose V., Tall F., Mead G.C., et al. Epidemiological analysis of Salmonella enterica ssp. enterica serovars Hadar, Brancaster and Enteritidis from humans and broiler chickens in Senegal using pulsed-field gel electrophoresis and antibiotic susceptibility. J Appl Microbiol 99 (2005) 968-977